Hospira challenges FDA’s “unlawful” approval of Precedex generics

20-08-2014

Hospira challenges FDA’s “unlawful” approval of Precedex generics

sippakorn / Shutterstock.com

Illinois-based drug company Hospira has sued the US Food and Drug Administration (FDA), challenging its recent decision to approve generic versions of Precedex (dexmedetomidine hydrochloride).


Hospira, FDA, Precedex, Mylan, generics

LSIPR